AletheiaHQ
Sign In
DIR-B9-CGG-KOVH/LVL 2·Guided ArbitrageGuided multi-step solo arbitrage producing a concrete deliverable. Requires basic commercial judgment. Examples: formatting extracted data into a $99 compliance checklist and cold-emailing 500 affected businesses; translating a buried scientific abstract into a viral short-form script monetised via affiliate links./90% confidence
Return to Directory

Arbitrage AICONIC's SBIR Vendor Procurement via FOIA-Enabled Referral Network

Organization
AICONIC BIOSCIENCES with $305K SBIR money earmarked for vendor procurement but no established vendor relationships
Sector
Specialized gene therapy CROs seeking qualified SBIR-funded clients
Location
Location unspecified

Source Reference

https://www.nsf.gov/awardsearch/showAward?AWD_ID=2604905

// Procurement// Biotech// Negotiation// Grant Writing// Compliance// Import/Export// Data Scraping// Open-Source Intelligence

Executive Context

AICONIC BIOSCIENCES received $305K NSF SBIR Phase I funding for gene therapy research but faces a severe commercial execution gap between their research deliverables and the $100M+ required for FDA approval and market access. The SBIR program creates research capital without commercial infrastructure, generating multiple asymmetric opportunities around vendor procurement, commercial intelligence, and process IP capture.

Catalyst / Timing

AICONIC has $305K SBIR money that MUST be spent within 18 months on specific technical deliverables, but as a small startup they lack established vendor relationships and procurement expertise for specialized gene therapy CRO services.

Projected Yield

15% referral fees on $91.5K+ vendor spend = $13,725+ from AICONIC alone

Structural Friction

• Vulnerability: AICONIC has $305K SBIR money that MUST be spent within 18 months on specific technical deliverables, but as a small startup they lack established vendor relationships and procurement expertise for specialized gene therapy CRO services. • Capital yield: 15% referral fees on $91.5K+ vendor spend = $13,725+ from AICONIC alone • Resource capture: Network of CRO referral agreements • Sovereignty yield: Position as procurement gateway for SBIR-funded biotechs • Required vectors: Vector: FOIA/Public Records, Vector: Vendor Research, Vector: Business Development Outreach

Required Capabilities

  • Vector: FOIA/Public Records

    Primary executor: Phase 1: FOIA for Vendor Procurement Details: Submit FOIA request to NSF for AICONIC's SBIR Phase I proposal (excluding

  • Vector: Vendor Research

    Supporting vector for: Arbitrage AICONIC's SBIR Vendor Procurement via FOIA-Enabled Referral Network

  • Vector: Business Development Outreach

    Supporting vector for: Arbitrage AICONIC's SBIR Vendor Procurement via FOIA-Enabled Referral Network

Execution Protocol

Execution Protocol Locked

A one-time payment of $49 unlocks the exact wedge, required assets, and step-by-step execution parameters yours forever, no subscription.

This report is synthesized intelligence, not verified instruction. Always confirm against the primary source before acting. Review the full legal disclaimer before proceeding.